Two mononuclear iron(II) complexes, [(6-amide-BPMEN)Fe](OTf) () and [(6-amide-Me-BPMEN)Fe(OTf)](OTf) (), supported by two BPMEN-derived (BPMEN = ,-dimethyl-,-bis(pyridine-2-yl-methyl)ethane-1,2-diamine) ligands bearing one or two amide functionalities have been isolated to study their reactivity in the oxygenation of C-H and C═C bonds using isopropyl 2-iodoxybenzoate (Pr-IBX ester) as the oxidant. Both and contain six-coordinate high-spin iron(II) centers in the solid state and in solution. The 6-amide-BPMEN ligand stabilizes an = 1 iron(IV)-oxo intermediate, [(6-amide-BPMEN)Fe(O)] ().
View Article and Find Full Text PDFThis study reports the development activities for the Treatment Preference Myelodysplasia Questionnaires (TPMQ) for clinicians (mTPMQ), carers (cTPMQ), and patients (pTPMQ). These tools are intended to evaluate treatment preferences for patients with myelodysplastic syndromes (MDS). This was a non-interventional, cross-sectional qualitative interview study consisting of interviews with clinicians, patients, and those caring for patients with MDS.
View Article and Find Full Text PDFHypomethylating agents are the most widely used upfront therapy for patients with myelodysplastic syndrome (MDS) who are not suitable for hematopoietic stem cell transplantation. In Australia, azacitidine was, until recently, the only approved and subsidized treatment for patients with intermediate-2 and high-risk MDS, chronic myelomonocytic leukemia, and low blast acute myeloid leukemia. We analyzed prescription data to evaluate the real-world persistence and overall survival (OS) of patients prescribed azacitidine for the first time in Australia.
View Article and Find Full Text PDFA cobalt catalyst, under oxidative conditions, facilitates the single electron transfer process in -pyridyl arylacetamides to form α-carbon-centered radicals that readily react with molecular oxygen, giving access to mandelic acid derivatives. In contrast to the known benzylic hydroxylation approaches, this approach enables chemo- and regioselective hydroxylation at a benzylic position adjacent to (-pyridyl)amides. Mild conditions, broad scope, excellent selectivity, and wide synthetic practicality set up the merit of the reaction.
View Article and Find Full Text PDFA mononuclear iron(II) complex, [(Tp)Fe(OTf)(CHCN)] (1) (Tp = hydrotris(3,5-diphenylpyrazol-1-yl)borate, OTf = triflate) has been isolated and its efficiency toward the aliphatic CC bond cleavage reaction of 1,2-diols with dioxygen has been investigated. Separate reactions between 1 and different 1,2-diolates form the corresponding iron(II)-diolate complexes in solution. While the iron(II) complex of the tetradentate TPA (tris(2-pyridylmethyl)amine) ligand is not efficient in affecting the CC cleavage of 1,2-diol with dioxygen, complex 1 displays catalytic activity to afford carboxylic acid and aldehyde.
View Article and Find Full Text PDF